Still no aducanumab filing and an in-house gathering triggered a health disaster, but Biogen's CEO nevertheless took home record pay

2020 got off to one of the most nightmarish starts in the industry at Biogen $BIIB as an annual meeting for its global execs turned …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Still no ad­u­canum­ab fil­ing and an in-house gath­er­ing trig­gered a health dis­as­ter, but Bio­gen's CEO nev­er­the­less took home record pay